Unmet Clinical Need |
A way to reduce procedural risks and increase effectiveness of the therapy delivery in the central nervous system which enables wider adoption by physicians
|
Healthcare Landscape |
Currently no FDA cleared medical device commercially available for CNS gene therapy delivery to the cisterna magna via lumbar access insertion
Creation of new market for gene therapy delivery and a novel platform technology for additional cerebrospinal fluid procedures |
Voice of the Customer
Direct sub-occipital puncture is done using fluoroscopy which is only |
I wanted to solve the problem of safely delivering CNS gene therapy. The Esperanza catheter system is designed to solve this problem and opens the window for other applications as a new platform technology!” |
Can also leverage your technology for other product / therapeutic areas in human body with “clear fluids” and “narrow spaces” due to its small size and video camera capability such as urinary system, respiratory system, subarachnoid hemorrhage, etc. |
Difficult to get trained neurosurgeons to do ICM approach to run clinical trials for gene therapies; not many people trained to do that procedure. So, it will be beneficial to have scalable procedure. |
The safe delivery of gene therapies is of utmost importance, so delivery techniques and |
Disclaimer: Product and related statements are not FDA cleared. The device is currently under development and is not commercially available for sale.